Albemarle Corporation (ALB) |
|
Price: $124.5800
$2.44
1.998%
|
Day's High:
| $125.74
| Week Perf:
| 0.52 %
|
Day's Low: |
$ 120.50 |
30 Day Perf: |
6.03 % |
Volume (M): |
1,886 |
52 Wk High: |
$ 247.44 |
Volume (M$): |
$ 234,970 |
52 Wk Avg: |
$169.69 |
Open: |
$123.73 |
52 Wk Low: |
$106.69 |
|
|
Market Capitalization (Millions $) |
14,672 |
Shares
Outstanding (Millions) |
118 |
Employees |
6,000 |
Revenues (TTM) (Millions $) |
9,617 |
Net Income (TTM) (Millions $) |
1,671 |
Cash Flow (TTM) (Millions $) |
-609 |
Capital Exp. (TTM) (Millions $) |
2,149 |
Albemarle Corporation
We are a leading global developer, manufacturer and marketer of highly-engineered
specialty chemicals that meet customer needs across a diverse range of end markets.
The end markets we serve include petroleum refining, consumer electronics, energy
storage, construction, automotive, lubricants, pharmaceuticals, crop protection,
food safety and custom chemistry services. We believe that our commercial and
geographic diversity, technical expertise, innovative capability, flexible,
low-cost global manufacturing base, experienced management team and strategic
focus on our core base technologies will enable us to maintain leading market
positions in those areas of the specialty chemicals industry in which we operate.
Lithium and Advanced Materials, Bromine Specialties and Refining Solutions.
Each segment has a dedicated team of sales, research and development, process
engineering, manufacturing and sourcing, and business strategy personnel and
has full accountability for improving execution through greater asset and market
focus, agility and responsiveness.
We develop and manufacture a broad range of basic lithium compounds, including
lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium
specialties and reagents, including butyllithium and lithium aluminum hydride.
Lithium is a key component in products and processes used in a variety of applications
and industries, which include lithium batteries used in consumer electronics
and automobiles, high performance greases, thermoplastic elastomers for car
tires, rubber soles and plastic bottles, catalysts for chemical reactions, organic
synthesis processes in the areas of steroid chemistry and vitamins, various
life science applications, as well as intermediates in the pharmaceutical industry,
among other applications. We also develop and manufacture cesium products for
the chemical and pharmaceutical industries, and zirconium, barium and titanium
products for various pyrotechnical applications, including airbag igniters.
Company Address: 4250 Congress Street, Suite 900 Charlotte 28209 NC
Company Phone Number: 299-5700 Stock Exchange / Ticker: NYSE ALB
|
|
Customers Net Income grew by |
ALB's Customers Net Profit Margin fell to |
1.3 % |
-0.09 %
|
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Stock Offering
Published Mon, Mar 4 2024 9:11 PM UTC
Albemarle Corporation, a global leader in essential elements for mobility, energy, connectivity, and health, recently announced its intention to conduct a proposed public offering of depositary shares. This move comes as the company aims to bolster its financial position and capitalize on market conditions. As of the time of writing this article, Albemarle Corporat...
|
Personnel Announcements
Published Thu, Feb 22 2024 9:40 PM UTC
CHARLOTTE, N.C., Feb. 22, 2024 - Albemarle Corporation (NYSE: ALB), a leading global specialty chemicals company, has recently announced that its Board of Directors has approved the declaration of a quarterly dividend worth $0.40 per share. This announcement comes even in the wake of the company's stock experiencing a significant decline of -3.59% over the past month.
|
Albemarle Corporation
Albemarle Corporation, a leading Chemicals - Plastics & Rubber company, recently reported a challenging fourth quarter in 2023, with a significant decline in both revenue and earnings per share. The company slipped into a deficit of $-5.25 per share, compared to $9.53 a year before, and earnings per share fell from $2.57 to $13.36 per share from the prior quarter. Revenue also experienced a notable decline of -10.104% to $2.36 billion from $2.62 billion in the corresponding quarter a year prior. The net deficit for the fourth quarter of 2023 was reported at $-603.292 million, a stark contrast to the net proceeds of $1,161.786 million in the same quarter the previous year. Despite a decrease in inventories to $2,161.3 million, relative to the previous quarter, there was still an increase compared to the same period a year ago. Additionally, the buildup in accounts receivable signals rising demand, with accounts receivables valued at $1,722.3 million, higher than in the preceding quarter.
|
Albemarle Corporation
Albemarle Corporation: Striving for Growth in a Challenging Market In the midst of a turbulent stock market landscape, Albemarle Corporation has maintained its resilience and commitment to achieving growth. While the recent fiscal period witnessed a decline in earnings per share (EPS), the company experienced a respectable increase in revenue, demonstrating its ability to adapt and thrive in a constantly evolving industry. Despite a challenging economic climate, Albemarle Corporation managed to elevate its revenue by a notable 10.459% to $2.31 billion, compared to the corresponding reporting season a year ago. This achievement is a testament to the company's strong market presence and its capacity to navigate through obstacles effectively. However, the downturn in EPS by -66.23% to $2.57 per share may cause concern to some, and prompt investors to reassess their expectations.
|
Albemarle Corporation
ALB Delivers Remarkable Earnings in Q2 2023, Proving Resilience in Challenging Chemicals Industry In the midst of a challenging period for the Chemicals - Plastics & Rubber industry, Albemarle Corporation (ALB) displayed its strength and resilience in its recently released financial report for the second quarter of 2023. The results were impressive, with ALB reporting a substantial increase in revenue, soaring by 60.192% to $2.37 billion. This growth is particularly significant considering the struggles faced by many companies within the industry, grappling with receding businesses and declining revenue. Earnings per share (EPS) also witnessed a substantial jump of 59.54% to $5.52 per share, compared to the same reporting period a year ago.
|
Per Share |
Current |
Earnings (TTM) |
13.35 $ |
Revenues (TTM) |
81.66 $
|
Cash Flow (TTM) |
- |
Cash |
-
|
Book Value |
82.06 $
|
Dividend (TTM) |
1.59 $ |
|
Per Share |
|
Earnings (TTM) |
13.35 $
|
Revenues (TTM) |
81.66 $ |
Cash Flow (TTM) |
- |
Cash |
-
|
Book Value |
82.06 $ |
Dividend (TTM) |
1.59 $ |
|
|
|
|